The Application of Chitosan-Based Nanocarrier for Oral Protein Drug/Vaccine Delivery
Ping GAO,Gui-Xue XIA,Zi-Xian BAO,Ya LIU,Xiao-Jie CHENG,Ming KONG,Chao FENG,Xi-Guang CHEN
DOI: https://doi.org/10.16441/j.cnki.hdxb.20160213
2017-01-01
Periodical of Ocean University of China
Abstract:In recent years,infectious bacterial and viral diseases have restricted the development of fish aquaculture.Oral immunization of fish has caused extensive attention because of its convenient operation with no restricted time,place,the sizes and no injury to fish.But oral vaccine may be degraded by digestive enzymes in the gastrointestinal tract (GI),which lead to the low immune efficiency.Therefore,with the rapid development of nanotechnology,the potent combination of chitosan (CS) based-nanocartiers with aquatic vaccines has caused much attention in the field of fish oral vaccination.Chitosan-nanoparticles (CS-NPs) and chitosan/carboxymethyl chitosan-nanoparticles (CS/CMCS-NPs) were prepared by ionic gelation and polyelectrolyte complexation method,respectively.Their average particle sizes were (178 ± 6.27)and (255 ± 7.54) nm,respectively.The zeta potential was (+15.9 ± 0.37) and (+16.4 ± 0.51) mV,respectively.The model protein of bovine serum albumin (BSA) was encapsulated in nanoparticles with the encapsulation efficiency (EE) of (42.9 ± 1.2)％ and (59.4 ± 3.2)％,respectively.The hemolysis and MTT assay showed that CS/CMCS-NPs exhibited better biocompatibility compared with CS-NPs.In order to evaluate cellular uptake efficiency of nanoparticles by Caco-2 cells,the nanocarriers were labeled with Cy5.5.The results showed that the cellular uptake efficiency revealed concentration-dependence and time-dependence in the certain range of concentration and time.For the sake of tracing the biodistribution of BSA encapsulated in nanoparticles,BSA was labeled with FITC.After oral administration in turbot with nanoparticles 36 hours later,the fluorescent proteins were mainly distributed in liver and foregut with the group of FITC-BSA:CS-NPs,while in hindgut,liver and spleen with the group of FITC-BSA:CS/CMCS-NPs.As for the control group,there were mainly distributed in liver.Thus,CS/CMCS-NPs could effectively protect the protein to reach the hindgut of turbot and had great potential to be applied as safe and effective oral vaccine delivery.